1. (2011) A clinical trial comparing efficacy and safety of sunitinib versus placebo for the treatment of patients at high risk of recurrent renal cell cancer (S-TRAC). http://clinicaltrials.gov/show/NCT00375674
2. (2011) Everolimus in treating patients with kidney cancer who have undergone surgery. http://clinicaltrials.gov/ct/show/NCT01120249
3. (2011) Monoclonal antibody therapy (Rencarex®) in treating patients who have undergone surgery for non-metastatic kidney cancer. http://clinicaltrials.gov/ct2/show/NCT00087022
4. (2011) Sorafenib in treating patients at risk of relapse after undergoing surgery to remove kidney cancer. http://clinicaltrials.gov/ct/show/NCT00492258
5. (2011) Study comparing 12 months versus 36 months of imatinib in the treatment of gastrointestinal stromal tumor (GIST). http://clinicaltrials.gov/ct2/show/NCT00116935